Previous Issue - Issue 04
This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
Issue 04 | 2024
- Foreword
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Information Technology
- Expert Talk
- Advertorials Go to Digital Magazine
Issue 04
PREVIOUS ISSUE
Foreword
Future Forward
AI's Impact on Drug Development
In the fastchanging world of drug development Artificial Intelligence AI is bringing about exciting and transformative changes
Strategy
Revolutionizing Medicine
The Pivotal Role of Artificial Intelligence in Drug Discovery and Medical Device Design
In the rapidly evolving landscape of healthcare and medical research the advent of artificial intelligence AI has marked a transformative era
Research & Development
Accelerating the Drug Development Process
The bodys immune system exhibits a remarkable ability to scrutinize a cells interior a function of central importance
Unlocking Capsules Potential
Expediting Drug Development in a Fast-Moving Market
In todays everevolving global context the demand for novel medications to combat emerging pathogens and rare diseases has reached unprecedented levels
Artificial Intelligence in Drug Development
Innovations and Challenges
Although Artificial Intelligence AI took root in the mid twentieth century shortly after the advent of computers
Clinical Trials
Nutraceuticals Unveiled
A Holistic Odyssey to Wellness
In an era where healthconsciousness is on the rise and preventative medicine takes center stage the concept of nutraceuticals emerges as a beacon of hope for individuals seeking holistic wellbeing
Manufacturing
Lean Supply Chain Management in Pharma Sector
In the pharmaceutical industry where efficiency and adaptability are crucial companies face unique challenges ranging from stringent regulations to complex manufacturing processes
Information Technology
Applying AI and ML to Optimise Processes and Enhance Patient Safety in Pharmacovigilance
One of the principal objectives of clinical studies is to test the safety of drugs and ascertain potential Adverse Drug Reactions ADRs
Expert Talk
Gen AI in PV and Regulatory Affairs
Generative AI has already started transforming many industries and the impact on the life sciences is no different
ADCs and their Drug Development Process
Antibodydrug conjugates ADCs have made great progress in recent years targeting more than recognized antigens today
Biopharmaceuticals and Biosimilars
Market Trends and Future Prospects
Biologics have become mainstay treatments for many chronic and acute diseases
